MediXall Group, Inc. notified the SEC that it will file its Form 10-Q for the period ended June 30, 2026 late, citing that certain financial and other information could not be prepared within the deadline without unreasonable effort or expense. The company indicated it does not anticipate any significant change in results of operations versus the same period last year in the upcoming report. MediXall also disclosed it is delinquent on multiple prior reports, including the 2024 and 2025 Forms 10-K and several Forms 10-Q for periods in 2025 and early 2026, which are still being prepared for submission.
MediXall Group, Inc. submitted a Form 12b-25 notification dated May 15, 2026 reporting a late filing for the period ended March 31, 2026. The company cites that "certain financial and other information" could not be provided without "unreasonable effort or expense." The filing states the company is delinquent in its 2024 Form 10-K, the Form 10-Qs for the quarters ended March 31, 2025, June 30, 2025 and September 30, 2025, and the 2025 Form 10-K, and that it is preparing those reports for submission.
MediXall Group, Inc. filed a Form 12b-25 notifying the SEC of a late annual report for the period ended December 31, 2025. The company cites that certain financial and other information could not be provided without "unreasonable effort or expense" and states it is delinquent in its 2024 Form 10-K and three 2025 Form 10-Qs. The notice is signed by Travis Jackson, CFO on March 31, 2026.